1-2 of 2
Dhruv Kumar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Time-limited pirtobrutinib, venetoclax, and obinutuzumab combination in first-line chronic lymphocytic leukemia

Free
Nitin Jain, Alessandra Ferrajoli, Mahesh Swaminathan, Jan Burger, Vanthana Bharathi, Wei-Ying Jen, Himachandana Atluri, Alex Bataller, Elias Jabbour, Tapan Kadia, Gautam Borthakur, Koichi Takahashi, Kelly Chien, Musa Yilmaz, Naveen Pemmaraju, Naval Daver, Fadi Haddad, Yesid Alvarado Valero, Jo Ishizawa, Guillermo Montalban-Bravo, Cameron Noorbakhsh, Dhruv Kumar, Naveen Garg, Hyunsoo Hwang, Wei Qiao, Cameron Garcia, Anna Evangelio, Ana Ayala, Guillermo Garcia-Manero, Deepa Sampath, Varsha Gandhi, Michael Keating, Hagop Kantarjian, William Wierda
Journal: Blood
Blood (2025) 146 (Supplement 1): 680.
https://doi.org/10.1182/blood-2025-680
Published: 2025
Journal Articles

Acalabrutinib plus rituximab followed by brexucabtagene autoleucel for frontline treatment of high-risk Mantle Cell Lymphoma: The window-3 clinical trial

Free
Preetesh Jain, Sairah Ahmed, Chi Young Ok, Ranjit Nair, Ahmed Fetooh, Holly Hill, Tatiana Vasilyeva, Ajlan Al Zaki, Anastasiya Evdokimova, Viktor Smirnov, Tolina Turova, Ilya Anosov, Lizzie Sheehan, Selvi Thirumurthi, Anita Deswal, Cezar Iliescu, Vinh Nguyen, Joel Thomas, Naveen Garg, Dhruv Kumar, Cameron Noorbakhsh, Sa Wang, Keyur Patel, Francisco Vega, L. Jeffrey Medeiros, Guilin Tang, Partow Kebriaei, Neeraj Saini, Susan Wu, Bouthaina Dabaja, Nikkita Kotlov, Michael Goldberg, Cara Haymaker, Christopher Flowers, Sattva Neelapu, Michael Wang
Journal: Blood
Blood (2025) 146 (Supplement 1): 666.
https://doi.org/10.1182/blood-2025-666
Published: 2025